Login / Signup

Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.

Aaron P MitchellAlan C KinlawSharon Peacock-HintonStacie B DusetzinaAaron N WinnHanna K SanoffJennifer L Lund
Published in: The oncologist (2024)
Individuals with Medicaid and commercial insurance received high-priced treatments in similar proportion, after accounting for differences in case mix. However, modification by provider characteristics suggests that insurance type may influence treatment selection for some patient groups. Further work is needed to determine the relationship between insurance status and newer, high-price drugs such as immune-oncology agents.
Keyphrases
  • long term care
  • affordable care act
  • health insurance
  • palliative care
  • healthcare